Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Sep 16, 2022	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001346432-22-000005.pdf 0001346432-22-000005.rtf 0001346432-22-000005.xls
Sep 16, 2022	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001943584-22-000002.pdf 0001943584-22-000002.rtf 0001943584-22-000002.xls
Sep 15, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001140361-22-033411.pdf 0001140361-22-033411.rtf 0001140361-22-033411.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 14, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-22-000079.pdf 0000320017-22-000079.rtf 0000320017-22-000079.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 2, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000074.pdf 0000320017-22-000074.rtf
Sep 2, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001879231-22-000006.pdf 0001879231-22-000006.rtf 0001879231-22-000006.xls
Sep 2, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001334549-22-000007.pdf 0001334549-22-000007.rtf 0001334549-22-000007.xls
Aug 19, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0000320017-22-000071.pdf 0000320017-22-000071.rtf 0000320017-22-000071.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 15, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000067.pdf 0000320017-22-000067.rtf
Aug 10, 2022	425	Filing of certain prospectuses and communications in connection with business combination transactions	View HTML 0000320017-22-000064.pdf 0000320017-22-000064.rtf